Quality Improvement in Health Care (한국의료질향상학회지)

Korean Society for Quality in Health Care (한국의료질향상학회)
권호 표지
DOI QR코드

DOI QR Code

Change in Quality of Tuberculosis (TB) Care since National Quality Assessment Program of TB Healthcare Service

결핵 적정성 평가에 따른 국내 결핵 진료서비스 질 관리 현황

  • Jang, Seong-Ja (Division of Quality Assessment, Health Insurance Review & Assessment Service) ;
  • Hwang, Mi-Jin (Division of Quality Assessment, Health Insurance Review & Assessment Service) ;
  • Lee, Chung-Hun (Division of Quality Assessment, Health Insurance Review & Assessment Service) ;
  • Lee, Hyeon-Ju (Division of Quality Assessment, Health Insurance Review & Assessment Service) ;
  • Shim, Tae-Sun (Division of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Dong-Sook (Division of Quality Assessment, Health Insurance Review & Assessment Service)
  • 장성자 (건강보험심사평가원 평가실 평가2부) ;
  • 황미진 (건강보험심사평가원 평가실 평가2부) ;
  • 이충훈 (건강보험심사평가원 평가실 평가2부) ;
  • 이현주 (건강보험심사평가원 평가실 평가2부) ;
  • 심태선 (울산대학교 의과대학 서울아산병원 호흡기내과) ;
  • 김동숙 (건강보험심사평가원 평가실 평가2부)
  • Received : 2021.11.10
  • Accepted : 2021.12.10
  • Published : 2021.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study aims to examine the quality of tuberculosis (TB) care after the 1st to 3rd national quality assessment (QA) program for TB healthcare service in Korea was conducted. Methods: We analyzed Health Insurance Review & Assessment Service (HIRA) claims data of new TB patients during the period of January to June from 2018-2020. The new TB patients were defined as TB patients reported to Korea Centers for Disease Control and Prevention Agency (KCDA). The unit of analysis was the patient. Chi-square tests were used to analyze the differences in indicator value according to the types of medical facilities. The QA indicators of TB care were divided into 3 areas consisting of the following 7 quality indicators: 4 indicators of diagnosis test (the rate of acid-fast bacilli smear, the rate of acid-fast bacilli culture, the rate of Mycobacterium tuberculosis-polymerase chain reaction, drug susceptibility test), 1 compliance of treatment guideline, and 2 indicators of care management of TB patients (encounter rate, day of therapy). Results: The QA program for TB care was conducted among 8,246 patients from 534 facilities in 2020. The value of the 7 quality indicators was shown to increase as a result of the QA program. The indicators of the diagnostic test were all higher than 95%, with the exception of the drug susceptibility test which was 84.8%. Both indicators for care management of TB patients were 88.5%. Conclusion: The quality of TB care has been improving with the implementation of the QA program. In order to continue to improve the quality of TB care, it will be necessary to disclose the results of the QA program in medical facilities in the future.

Keywords

References

  1. Shin J, Kim J, In HK, Shim E. Analysis of the 2nd quality assessment on tuberculosis care in Korea. Public Health Weekly Report. 2020;13(44):3153-60.
  2. World Health Organization. Global tuberculosis report 2020 [Internet]. Geneva, Swiss: World Health Organization; 2020 [cited 2020 Nov 28]. Available from: https://apps.who.int/iris/handle/10665/336069.
  3. Kim J, Shin JY, In HK, Shim E. Review on global burden of tuberculosis in 2019: Global tuberculosis report 2020, WHO. Public Health Weekly Report. 2020;13(44):3169-75.
  4. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. Morbidity and Mortality Weekly Report: Recommendations and Reports. 2005;54(RR-17):1-140.
  5. Sia IG, Wieland ML. Current concepts in the management of tuberculosis. Mayo Clinic Proceedings. 2011;86(4):348-61. https://doi.org/10.4065/mcp.2010.0820
  6. Choi Y, Tae Y, Kim J. Influential factors to prolonged tuberculosis treatment duration and multidrug-resistant tuberculosis incidence. Journal of Health Informatics and Statistics. 2016;41(3):344-50. https://doi.org/10.21032/jhis.2016.41.3.344
  7. 「Infectious Disease Control and Prevention (act 17475)」 Korea Disease Control and Prevention Agency, Ministry of Health and Welfare.
  8. Ministry of Health and Welfare, Korea Disease Control and Prevention Agency. The first national plan for tuberculosis management (2013-2017). Sejong, Korea: Ministry of Health and Welfare; 2013.
  9. Ministry of Health and Welfare, Korea Disease Control and Prevention Agency. The second national plan for tuberculosis management (2018- 2022). Sejong, Korea: Ministry of Health and Welfare; 2018.
  10. Ministry of Health and Welfare, Korea Disease Control and Prevention Agency. The plan of reinforcement on tuberculosis management. Sejong, Korea: Ministry of Health and Welfare; 2019.
  11. Korea Disease Control and Prevention Agency, Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis fourth edition. Osong, Korea: Korea Disease Control and Prevention Agency; 2020.
  12. Son E, Jeon D. Current situation of tuberculosis and national strategic plan for tuberculosis control in Korea. Journal of the Korean Medical Association. 2021;64(4):316-23. https://doi.org/10.5124/jkma.2021.64.4.316
  13. Park J. Prevention of tuberculosis and isolation of tuberculosis patients in health care facilities. Journal of the Korean Medical Association. 2019;62(1):5-10. https://doi.org/10.5124/jkma.2019.62.1.5
  14. 「The act of national health insurance (17772)」 Ministry of Health and Welfare.
  15. Ministry of Health and Welfare. The plan of healthcare benefit quality assessment program 2021. Sejong, Korea: Ministry of Health and Welfare; 2021.
  16. Health Insurance Review & Assessment Service. The report of pilot quality assessment (QA) program. Wonju, Korea: Health Insurance Review & Assessment Service; 2017.
  17. Korea Disease Control and Prevention Agency. National tuberculosis report 2020. Osong, Korea: Korea Disease Control and Prevention Agency; 2020.